Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ARIX

Arix Bioscience (ARIX)

Arix Bioscience Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:ARIX
日付受信時刻ニュースソース見出しコード企業名
2024/02/1317 : 00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Arix Bioscience plcLSE:ARIXArix Bioscience Plc
2024/02/1221 : 53Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience shares suspended ahead of RTW takeoverLSE:ARIXArix Bioscience Plc
2024/02/1221 : 00EQS Regulatory NewsScheme EffectiveLSE:ARIXArix Bioscience Plc
2024/02/1216 : 00EQS Regulatory NewsSuspension of Trading in SharesLSE:ARIXArix Bioscience Plc
2024/02/0720 : 30EQS Regulatory NewsTransaction UpdateLSE:ARIXArix Bioscience Plc
2024/01/2921 : 15EQS Regulatory NewsResults of First General MeetingLSE:ARIXArix Bioscience Plc
2024/01/2502 : 30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
2024/01/2502 : 30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
2024/01/2502 : 30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
2024/01/2316 : 00EQS Regulatory NewsUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
2024/01/2316 : 00UK RegulatoryUpdate on the Scheme and Publication of Notice of Second General MeetingLSE:ARIXArix Bioscience Plc
2024/01/2301 : 22Alliance NewsAlliance NewsIN BRIEF: RTW Biotech completes Arix investment in takeover run-upLSE:ARIXArix Bioscience Plc
2024/01/2216 : 00EQS Regulatory NewsUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
2024/01/2216 : 00UK RegulatoryUpdate on the Scheme and Resignation of DirectorsLSE:ARIXArix Bioscience Plc
2024/01/1920 : 29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:ARIXArix Bioscience Plc
2024/01/1916 : 01EQS Regulatory NewsFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
2024/01/1916 : 01UK RegulatoryFinancial update on Harpoon Therapeutics acquisition by Merck (MSD)LSE:ARIXArix Bioscience Plc
2024/01/1916 : 00EQS Regulatory NewsUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
2024/01/1916 : 00UK RegulatoryUnaudited NAV for December 2023LSE:ARIXArix Bioscience Plc
2024/01/0902 : 15EQS Regulatory NewsPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
2024/01/0902 : 15UK RegulatoryPortfolio company Harpoon Therapeutics to be acquired by Merck (MSD)LSE:ARIXArix Bioscience Plc
2024/01/0516 : 00EQS Regulatory NewsPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
2024/01/0516 : 00UK RegulatoryPublication of Circular and RTW Bio ProspectusLSE:ARIXArix Bioscience Plc
2024/01/0502 : 30EQS Regulatory NewsHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
2024/01/0502 : 30UK RegulatoryHolding(s) in CompanyLSE:ARIXArix Bioscience Plc
2023/12/2220 : 00UK RegulatoryUpdate regarding timing of Proposed Scheme of ReconstructionLSE:ARIXArix Bioscience Plc
2023/12/1316 : 00UK RegulatoryUnaudited NAV for November 2023LSE:ARIXArix Bioscience Plc
2023/12/0816 : 00UK RegulatoryPortfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass TrialLSE:ARIXArix Bioscience Plc
2023/11/1401 : 00UK RegulatoryCorrection: Portfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
2023/11/1017 : 00UK RegulatoryPortfolio Company Aura Biosciences Announces Closing of USD99 million Public Offering of Common StockLSE:ARIXArix Bioscience Plc
 Showing the most relevant articles for your search:LSE:ARIX

最近閲覧した銘柄

Delayed Upgrade Clock